KBC Group
RDY icon

KBC Group’s Dr. Reddy's Laboratories RDY Stock Holding History

KBC Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95K Buy
6,547
+1,054
+19% +$14.2K ﹤0.01% 1453
2026
Q1 		$76K Buy
+5,493
New +$76.5K ﹤0.01% 1478
2014
Q3 		– Sell
-21,465
Closed -$185K – 1328
2014
Q2 		$185K Sell
21,465
-14,860
-41% -$125K ﹤0.01% 1082
2014
Q1 		$319K Hold
36,325
– – 0.01% 898
2013
Q4 		$298K Sell
36,325
-6,410
-15% -$50.7K ﹤0.01% 937
2013
Q3 		$323K Hold
42,735
– – 0.01% 904
2013
Q2 		$323K Buy
+42,735
New +$312K 0.01% 905

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

KBC Group's RDY Position: Q2 2026 in Review

KBC Group increased its Dr. Reddy's Laboratories (RDY) stake by 19% in Q2 2026, buying an estimated $14.2K and bringing the position to 6,547 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

KBC Group first reported a position in RDY in Q2 2013 and has held it in 7 quarters since. The position peaked at $323K in Q3 2013. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • KBC Group held 6,547 shares of Dr. Reddy's Laboratories worth $95K as of Q2 2026.
  • KBC Group bought 1,054 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $14.2K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1453 holding.
  • KBC Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 7 quarters since.
  • KBC Group's Dr. Reddy's Laboratories position peaked at $323K in Q3 2013.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.